NOCD
NOCD is the world's largest dedicated telehealth provider of OCD treatment, delivering evidence-based ERP therapy via live video to patients across all 50 US states, Canada, the UK, and Australia, with revenue intermediated through 70+ insurance plans covering 137 million commercial lives.
- Company typePrivate
- Founded2015
- HeadquartersChicago, United States
- Headcount101–250
- GTM typeB2C
- OfferingServices
What NOCD does
NOCD (NOCD Inc.) is a Chicago-based telehealth provider specializing in the treatment of obsessive-compulsive disorder, operating as the world's largest dedicated OCD treatment platform. The company delivers Exposure and Response Prevention (ERP) therapy — the evidence-based first-line treatment for OCD — via live, face-to-face video sessions with specialty-trained therapists licensed across all 50 US states, Canada, the UK, and Australia. The core product suite consists of NOCD Therapy (live video ERP sessions), the NOCD App (between-session therapist messaging, self-directed ERP tools, and a peer community of approximately 1 million members), the Intensive Treatment Program (a 3-6 week virtual intensive outpatient program combining daily group and individual ERP and CBT), and NOCD Academy (free continuing education courses for healthcare providers). All therapists complete graduate-level ERP training supervised by the company's clinical leadership team, and outcomes are validated by the largest peer-reviewed studies of OCD treatment to date (3,552 adults; 2,173 children/adolescents), showing a 43.4% mean symptom reduction in under 12 weeks.
NOCD's business model is primarily insurance-billed specialty telehealth. Approximately 137 million commercial lives are covered through partnerships with 70+ health plans including Kaiser Permanente, Aetna, Cigna, BCBS, and United/Optum, enabling patients to access therapy via standard copays. Out-of-pocket payment options, including interest-free payment plans, are offered for the cash-pay Intensive Treatment Program ($7,400 for the first three weeks). The go-to-market combines direct-to-consumer digital acquisition (organic social, YouTube, TikTok, SEO-driven content) with structured provider referral channels and payer-driven in-network access. Customers are individuals with OCD aged 5 and older, including adults and children, addressing a documented 14-17 year average delay in diagnosis and a 70% misdiagnosis rate in traditional care.
In early 2025, NOCD achieved its first month of positive EBITDA and acquired Rebound Health, a Prolonged Exposure-based PTSD treatment platform. Both brands were restructured under a newly created parent company called Noto, described as an AI-enabled platform designed to scale specialty mental health care. NOCD has raised approximately $84 million since 2018 from investors including F-Prime Capital (Series B lead), 7wireVentures, Cigna Ventures, Kaiser Permanente Ventures, Eight Roads Ventures, Health Enterprise Partners, and Longitude Capital, reaching a valuation of nearly $270 million in 2024.
NOCD firmographics
Firmographics- Name
- NOCD
- Legal name
- NOCD Inc.
- Website
- https://treatmyocd.com
- Company type
- Private
- Founded year
- 2015
- Operating status
- Operating
- Headcount range
- 101–250 employees
- Short description
- NOCD is the world's largest dedicated telehealth provider of OCD treatment, delivering evidence-based ERP therapy via live video to patients across all 50 US states, Canada, the UK, and Australia, with revenue intermediated through 70+ insurance plans covering 137 million commercial lives.
- Ownership category
- akta.pro rank
NOCD industry classification
Industry- Product category
- OCD Telehealth Therapy
- NAICS
- Outpatient Mental Health and Substance Abuse Centers (621420), Outpatient Mental Health and Substance Abuse Centers (62142)
- SIC
- Services-Specialty Outpatient Facilities, Nec (8093), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching) (HLALAEAJ)
- akta.pro secondary industry
- Behavioral Health Partial Hospitalization & Intensive Outpatient Programs (PHP/IOP) (HLAFACAJ)
Keywords
Where NOCD is headquartered
LocationHeadquarters
- HQ city
- Chicago
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
NOCD business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Insurance-Covered Telehealth Therapy: NOCD bills insurance plans directly for therapy sessions. The company accepts 70+ health plans including major insurers like Kaiser Permanente, Aetna, Cigna, and Blue Cross Blue Shield. Members pay copays as determined by their insurance coverage.
- Out-of-Pocket / Cash Pay: For patients without adequate insurance coverage or seeking services not covered by insurance (such as the Intensive Treatment Program), NOCD offers out-of-pocket payment options with interest-free payment plans available.
- Intensive Treatment Program: The Intensive Treatment Program costs $7,400 for the first three weeks, with weekly billing continuing for the remainder of the six-week program. An admission assessment costs $240 and is billed separately.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Monthly | Standard Insurance-Covered ERP Therapy |
| One time/ perpetual license | Pay-as-you-go | Intensive Treatment Program - First 3 Weeks |
| Unit Pricing | Pay-as-you-go | Intensive Treatment Program - Weeks 4-6 |
Go-to-market motion1 record
Distribution channels3 records
Marketing channels12 records
NOCD product offering
Product offeringCore offering
NOCD operates an online behavioral health treatment platform that delivers specialized ERP (Exposure and Response Prevention) therapy for OCD via live, face-to-face video teletherapy sessions with licensed therapists trained in OCD treatment. The core offering is NOCD Therapy, consisting of twice-weekly 60-minute remote ERP video sessions for three weeks followed by once-weekly 30-minute check-ins, supported by 24/7 mobile app access including therapist messaging, real-time ERP tools, symptom tracking, and the world's largest OCD peer community. NOCD also offers a 3-6 week virtual Intensive Treatment Program for severe cases priced at $7,400 for the first three weeks.
Product overview
NOCD operates a telehealth platform centered on OCD treatment, combining live video ERP therapy with a mobile app for between-session support. The core offerings include NOCD Therapy (live video sessions with specialized therapists), the NOCD App (support tools, ERP exercises, and peer community), NOCD Academy (continuing education for providers), and an Intensive Treatment Program (virtual IOP for severe cases). In March 2025, NOCD acquired Rebound Health and created parent company Noto to expand into PTSD treatment and broader behavioral health conditions.
Differentiator
Problem solved
Functional benefit
Brands
- Rebound Health: Trauma recovery platform using Prolonged Exposure principles for PTSD treatment, operating as the second brand under Noto parent company.
- Noto
Products and services
- NOCD Therapy NOCD Therapy is a telehealth OCD treatment service delivering live, face-to-face video ERP (Exposure and Response Prevention) therapy sessions with specialty-trained licensed therapists. The standard treatment protocol includes twice-weekly 60-minute remote ERP video sessions for three weeks, followed by once-weekly 30-minute video check-in sessions, supported by 24/7 mobile app access to therapist messaging, real-time ERP tools, symptom tracking, and the world's largest OCD peer community. Therapy is covered by 70+ health plans including Kaiser Permanente, Aetna, Cigna, and Blue Cross Blue Shield, with patients paying applicable copays. For uninsured or underinsured patients, out-of-pocket payment options with interest-free payment plans are available. The service targets individuals with OCD (adults and children ages 5+) seeking evidence-based specialty care.
- Intensive Treatment Program The Intensive Treatment Program is a 3-6 week virtual intensive outpatient program (IOP) that combines daily group and individual therapy using ERP and CBT for adults with severe OCD who need more immersive support than standard weekly therapy. The program is priced at $7,400 for the first three weeks, with weekly billing continuing for the remainder of the 3-6 week program based on clinical need. An admission assessment costs $240 and is billed separately. The Intensive Treatment Program can lead to up to 47% symptom reduction.
Quantifiable outcome
- 43.4% mean reduction in OCD symptoms
- +11 more outcomes
Companies that use NOCD
Customer profileNamed customers1 record
Segments1 record
Ideal customer profiles2 records
NOCD technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature5 records
NOCD partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core.
- Rebound HealthcoreNOCD acquired Rebound Health, a trauma recovery platform using Prolonged Exposure principles for PTSD treatment. Rebound operates as the second brand under Noto, NOCD's AI-enabled parent platform. The acquisition expanded NOCD into PTSD treatment and added over 100 PE-trained specialists to its network.
- Kaiser PermanentecoreKaiser Permanente is a key insurance partner, with NOCD accepting Kaiser plans including Northern and Southern California regions. Kaiser Permanente Ventures also invested in NOCD.
- AetnacoreAetna is a major in-network insurance partner, with NOCD accepting Aetna plans across its network of therapists.
- CignacoreCigna is an in-network insurance partner for NOCD therapy services, with Cigna Ventures also providing investment.
- Blue Cross Blue ShieldcoreBlue Cross Blue Shield (BCBS) is an in-network insurance partner across multiple state plans including Illinois, Rhode Island, Massachusetts, Michigan, and Virginia.
- United Healthcare / OptumcoreUnited Healthcare and Optum are in-network insurance partners providing coverage for NOCD therapy services.
Scale indicators12 records
Recent moves3 records
Expansion highlights6 records
NOCD competitors and assessment
Company assessmentDirect peers
- Brightside Health: Telehealth mental health platform providing evidence-based therapy and medication management for depression, anxiety, and related conditions. Direct peer in virtual specialty behavioral health delivery with similar insurance-billed model and outcomes-focused positioning.
- Cerebral: Subscription-based telehealth platform focused on anxiety, depression, ADHD, and related conditions, with combined therapy and medication management. Direct competitor in insurance-billed virtual mental health for similar patient demographics.
- Talkiatry: Psychiatry-focused telehealth platform offering in-network medication management and therapy for conditions including anxiety, OCD, and PTSD. Direct peer in specialty virtual psychiatry with similar insurance-billed model and clinical-outcome orientation.
Broad incumbents
- Talkspace: Public online therapy platform offering text/video sessions with licensed therapists across mental health conditions. Competes for the same insured patient population and payer contracts but serves a much broader condition set with less specialization.
- BetterHelp: Largest consumer online therapy marketplace (owned by Teladoc). Competes broadly in virtual therapy delivery, including for OCD patients, though with a generalist therapist network rather than OCD specialization.
- Lyra Health: Enterprise mental health benefits provider serving large employers with a blended in-person and virtual provider network. Competes for payer and employer contracts and offers specialty care routing, including for anxiety and OCD.
Emerging players
- Spring Health: Employer-sponsored mental health benefits platform with personalized care routing across therapy, coaching, and medication. Competes for the same B2B payer channel and increasingly offers specialty care pathways that could include OCD-specific programs.
- Headway: Insurance-network and billing platform that helps therapists go in-network with major payers. Functions as both an enabler for NOCD's therapist network and a potential competitor building its own patient-facing therapy marketplace.
- Alma: Therapist network platform providing insurance billing, credentialing, and referrals. Comparable in building a scaled, insurance-friendly therapist network with similar payer relationships, though with a broader condition focus than NOCD.
- Two Chairs: Therapy platform operating hybrid in-person and virtual clinics with a matched-care model emphasizing therapist-client fit. Competes for in-network insured patients seeking specialized therapy, including anxiety and OCD.
Market position
Strengths4 records
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
NOCD social profiles
Digital presenceNOCD financial estimates
Financial estimateRevenue estimate
Valuation estimate
NOCD leadership team
Management profileNumber of profiles
Profiles14 records
NOCD subsidiaries and ownership
Company hierarchySubsidiaries2 records
NOCD funding detail
Funding detailFunding overview
Funding rounds6 records
Investors11 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
NOCD M&A and investment
M&A and investmentM&A1 record
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about NOCD
What does NOCD do?
NOCD operates an online behavioral health treatment platform that delivers specialized ERP (Exposure and Response Prevention) therapy for OCD via live, face-to-face video teletherapy sessions with licensed therapists trained in OCD treatment. The core offering is NOCD Therapy, consisting of twice-weekly 60-minute remote ERP video sessions for three weeks followed by once-weekly 30-minute check-ins, supported by 24/7 mobile app access including therapist messaging, real-time ERP tools, symptom tracking, and the world's largest OCD peer community. NOCD also offers a 3-6 week virtual Intensive Treatment Program for severe cases priced at $7,400 for the first three weeks.
Is NOCD a public or private company?
NOCD is a private company. It is classified as venture growth investor backed and is currently operating.
When was NOCD founded?
NOCD was founded in 2015. It employs 101 to 250 people.
Where is NOCD based?
NOCD is headquartered in Chicago, United States, in the North America region.
How does NOCD make money?
Three revenue lines are on record. Insurance-Covered Telehealth Therapy is the primary driver. The others are out-of-Pocket / Cash Pay and intensive Treatment Program.
Who are NOCD's main competitors?
Direct peers on record are Brightside Health, Cerebral and Talkiatry. Broad incumbents are Talkspace, BetterHelp and Lyra Health. Emerging players are Spring Health, Headway, Alma and Two Chairs.
Does NOCD have an API?
No public API is recorded for NOCD.
What industry is NOCD in?
NOCD's product category is OCD Telehealth Therapy. Its primary akta.pro industry code is HLALAEAJ, Neurodevelopmental & Behavioral Therapy Platforms (ADHD/Autism/Behavioral Coaching), with a secondary code of HLAFACAJ, Behavioral Health Partial Hospitalization & Intensive Outpatient Programs (PHP/IOP). Its NAICS code is 621420 and its SIC code is 8093.